课题基金 / 基金详情

Post-Vent, the Sequelae: Personalized Prognostic Modeling for Consequences of Neonatal Intermittent Hypoxemia in Preterm Infants at Pre-School Age

Post-Vent, the Sequelae: Personalized Prognostic Modeling for Consequences of Neonatal Intermittent Hypoxemia in Preterm Infants at Pre-School Age
排气后的后遗症:学龄前早产儿新生儿间歇性低氧血症后果的个性化预后模型
批准号:
10541156
负责人:
Namasivayam Ambalavanan
金额:
$152.13万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-12-15 至 2026-11-30
关键词:
AccelerationAgeAge MonthsAsthmaBreathingBronchopulmonary DysplasiaCaffeineCharacteristicsChildChild CareChildhoodClinicalClinical DataClinical TreatmentCognitiveCollaborationsConsentDataDevelopmentDiagnosisDiscipline of NursingDiseaseEarly DiagnosisEarly InterventionEarly identificationEmotionalEnrollmentEventFrequenciesFundingFutureGoalsHealthHypoxemiaImpairmentInfantInfrastructureInstitutionInterventionIntervention TrialInvestigationKnowledgeLifeLinkMeasuresMotorNational Heart, Lung, and Blood InstituteNeonatalNeonatal Intensive CareNeonatal Intensive Care UnitsNervous System PhysiologyNeurodevelopmental ImpairmentNursery SchoolsOutcomeOxygenPathologicPathway interactionsPatientsPatternPersonsPharmaceutical PreparationsPhysiologicalPopulationPregnancyPremature BirthPremature InfantPrevalencePrevention strategyPreventivePrognosisProspective StudiesProtocols documentationRecordsRehabilitation therapyResearchResearch PersonnelResolutionResourcesRespiratory physiologyRiskRodentRoleSchool-Age PopulationSensoryServicesSleepSleep Apnea SyndromesStructureSystemTherapeuticTimeTrainingUnited States National Institutes of HealthVentWeaningWorkadvanced analyticsairway hyperresponsivenessasthma modelclinical careclinical phenotypecohortcostearly screeningempowermentexperienceextreme prematurityimprovedinfancyinnovationnegative affectneonatal carenovel therapeuticspeerpostnatalprematureprognosticprognostic modelprogramsrespiratoryresponsestandard of caresupplemental oxygentargeted treatment

项目摘要

项目成果

Namasivayam Ambalavanan的其他基金

相似基金

相关文献

中文摘要
翻译
项目摘要/摘要
英文摘要
Project Summary / Abstract This is the application from collaborators of the Prematurity-Related Ventilatory Control (Pre-Vent): Role in Respiratory Outcomes NHLBI Collaborative Program. Central to this proposal is a prospective study entitled “Post-Vent, the Sequelae: Personalized Prognostic Modeling for Consequences of Neonatal Intermittent Hypoxemia in Preterm Infants at Pre-school Age”. This multicenter proposal innovatively combines detailed clinical phenotyping with advanced analytics of longitudinal recordings of intermittent hypoxemia (IH) events to develop personalized prognostic models of long-term outcomes that could transform clinical care by allowing for timely identification of at-risk infants and specific pathologic IH patterns for future trials of targeted intervention. Extremely premature birth and various postnatal factors can negatively affect outcome. In a significant proportion of extremely premature infants the sequelae persist beyond infancy with relatively high rates of asthma and sleep disordered breathing (SDB) in childhood and worrisome prevalence of neurodevelopmental impairment (NDI). This multicenter proposal will systematically and innovatively examine the interaction between IH during neonatal intensive care and these sequelae by means of detailed clinical phenotyping and advanced analytics. The proposed investigation will provide personalized prognosis and identification of infants at risk of poor long-term outcome that could transform clinical care and uncover targets for preventive or therapeutic strategies. The main goal of this proposal is to build prognostic models of asthma, SDB, and NDI at pre-school age in former extremely premature infants based on physiologic waveforms and clinical characteristics in the neonatal intensive care unit. To achieve this goal this time-sensitive proposal leverages the population, research structure and expertise, and analytic resources developed for the NHLBI-funded Pre-Vent collaboration.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Let-7b in BPD
  • 批准号:
    10655734
  • 项目类别:
  • 资助金额:
    $55.44万
  • 财政年份:
    2023
  • 负责人:
    Namasivayam Ambalavanan
  • 依托单位:
Prapela® SVS incubator pad: A cost-effective stochastic vibrotactile device to improve the clinical course of infants with apnea of prematurity.
  • 批准号:
    10576754
  • 项目类别:
  • 资助金额:
    $50.02万
  • 财政年份:
    2023
  • 负责人:
    Namasivayam Ambalavanan
  • 依托单位:
Vital Signs In Opioid-Exposed Neonates
  • 批准号:
    10493363
  • 项目类别:
  • 资助金额:
    $50.77万
  • 财政年份:
    2021
  • 负责人:
    Namasivayam Ambalavanan
  • 依托单位:
UAB Clinical Site HEAL Neonatal Opioid Withdrawal Pharmacological Treatments
  • 批准号:
    10891299
  • 项目类别:
  • 资助金额:
    $22.15万
  • 财政年份:
    2021
  • 负责人:
    Namasivayam Ambalavanan
  • 依托单位:
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: